Maridea Wealth Management LLC Invests $1.33 Million in Rentokil Initial PLC $RTO

Maridea Wealth Management LLC acquired a new stake in Rentokil Initial PLC (NYSE:RTOFree Report) during the third quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund acquired 49,809 shares of the company’s stock, valued at approximately $1,334,000.

A number of other institutional investors also recently modified their holdings of the company. Jane Street Group LLC increased its stake in shares of Rentokil Initial by 292.0% during the first quarter. Jane Street Group LLC now owns 117,341 shares of the company’s stock valued at $2,687,000 after buying an additional 87,405 shares during the period. IFP Advisors Inc boosted its stake in Rentokil Initial by 115.5% during the second quarter. IFP Advisors Inc now owns 1,282 shares of the company’s stock worth $31,000 after acquiring an additional 687 shares in the last quarter. Vanguard Personalized Indexing Management LLC purchased a new stake in shares of Rentokil Initial in the 2nd quarter worth approximately $317,000. Exencial Wealth Advisors LLC increased its holdings in shares of Rentokil Initial by 6.5% during the second quarter. Exencial Wealth Advisors LLC now owns 47,919 shares of the company’s stock valued at $1,150,000 after acquiring an additional 2,934 shares in the last quarter. Finally, Ethic Inc. bought a new position in shares of Rentokil Initial in the second quarter worth approximately $212,000. 9.91% of the stock is currently owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

A number of equities analysts have weighed in on the company. Weiss Ratings reissued a “hold (c-)” rating on shares of Rentokil Initial in a research report on Thursday, January 22nd. Bank of America upgraded shares of Rentokil Initial from a “neutral” rating to a “buy” rating and set a $34.00 target price on the stock in a report on Thursday, December 18th. JPMorgan Chase & Co. reaffirmed an “overweight” rating on shares of Rentokil Initial in a research report on Friday, November 21st. Rothschild & Co Redburn cut Rentokil Initial from a “hold” rating to a “strong sell” rating in a report on Friday, January 30th. Finally, Morgan Stanley raised Rentokil Initial from an “equal weight” rating to an “overweight” rating in a report on Tuesday, January 6th. One investment analyst has rated the stock with a Strong Buy rating, five have given a Buy rating, two have assigned a Hold rating and two have assigned a Sell rating to the company. Based on data from MarketBeat, Rentokil Initial presently has an average rating of “Moderate Buy” and an average price target of $34.00.

Read Our Latest Report on Rentokil Initial

Rentokil Initial Stock Up 1.2%

Shares of NYSE RTO opened at $30.83 on Wednesday. Rentokil Initial PLC has a 52-week low of $19.60 and a 52-week high of $33.46. The company has a current ratio of 1.12, a quick ratio of 1.03 and a debt-to-equity ratio of 0.79. The firm’s fifty day moving average is $30.94 and its two-hundred day moving average is $27.80.

About Rentokil Initial

(Free Report)

Rentokil Initial PLC is a global business services company specializing in pest control, hygiene and workwear services. Headquartered in Crawley, West Sussex, United Kingdom, the company delivers outsourced solutions designed to protect people, preserve assets and enhance workplaces for both commercial and residential customers.

Under the Rentokil Pest Control brand, the company offers services ranging from routine inspections and treatment of insects, rodents and birds to specialised programmes for food manufacturing and healthcare environments.

Recommended Stories

Want to see what other hedge funds are holding RTO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Rentokil Initial PLC (NYSE:RTOFree Report).

Institutional Ownership by Quarter for Rentokil Initial (NYSE:RTO)

Receive News & Ratings for Rentokil Initial Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Rentokil Initial and related companies with MarketBeat.com's FREE daily email newsletter.